Pandite Arundathy N. 4
4 · Shattuck Labs, Inc. · Filed Jan 27, 2023
Insider Transaction Report
Form 4
Pandite Arundathy N.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-25+69,750→ 69,750 totalExercise: $3.57Exp: 2033-01-25→ Common Stock (69,750 underlying) - Award
Common Stock
2023-01-25+37,875→ 175,792 total
Footnotes (2)
- [F1]Consists of 37,875 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represents a right to purchase a total of 69,750 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.